Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures

Published:2017-07-20 Issue:10 Volume:17 Page:1275-1296
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Vornicu Ovidiu¹,Larock Anne-Sophie²³,Dincq Anne-Sophie¹²,Douxfils Jonathan²⁴^ORCID,Dogné Jean-Michel²⁴,Mullier François²⁵,Lessire Sarah¹²⁴

Affiliation:

1. Department of Anesthesiology, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium

2. Namur Thrombosis and Hemostasis Center (NTHC) – NAmur Research Institute of LIfe Sciences (NARILIS), Namur, Belgium

3. Department of Pharmacy, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium

4. Department of Pharmacy, Faculty of Medicine, Université de Namur, Namur, Belgium

5. Hematology Laboratory, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2017.1349749

Reference107 articles.

1. Bleeding complications from the direct oral anticoagulants

2. Dabigatran and Postmarketing Reports of Bleeding

3. Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery

4. Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II

5. Direct Oral Anticoagulants

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The myths behind DOAC measurement: Analyses of prescribing information from different regulatory bodies and a call for harmonization;Journal of Thrombosis and Haemostasis;2022-11

2. Idarucizumab in major trauma patients: a single centre real life experience;European Journal of Trauma and Emergency Surgery;2019-09-25

3. Idarucizumab administration in emergency situations: the Munich Registry of Reversal of Pradaxa® in clinical routine (MR REPAIR);Journal of Neurology;2019-08-02

4. Andexanet alfa for the reversal of factor Xa inhibitors;Expert Opinion on Biological Therapy;2019-04-11

5. Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants – A systematic review;PLOS ONE;2019-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3